R’Kes Starling, RPh, MBA

Chief Executive Officer/President

Reveles Clinical Services

R’Kes Starling, RPh, MBA, is CEO and Founder of Reveles, Inc., a digital health company pioneering representation in clinical discovery. Through decentralized clinical trial approaches, R’Kes has been on the forefront of health equity in clinical research. He has more than 21 years of experience providing high-touch pharmacy services, clinical reach operations, specialty drug distribution, and clinical management to patients with rare and complex diseases such as chronic kidney disease, cancer, hemophilia, and cystic fibrosis. Prior to founding Reveles, R’Kes headed up the Specialty Pharmacy and Clinical Research Service businesses at McKesson, which comprised two separate business units of an oncology-focused specialty pharmacy and the “central depot” that provides investigational product distribution, accountability, and storage for the US Oncology Network. He oversaw a multidisciplinary clinical research team involved in more than 130 active oncology-focused clinical trials and was responsible for delivering more than 50,000 annual shipments of investigational products, laboratory kits, and clinical supplies to the US Oncology Network sites across the United States. Prior to McKesson, as the Vice President of Operations, he oversaw eight Home Infusion specialty pharmacies in six states with Coram CVS Specialty Infusion Services, which has translated into his in-depth experience and knowledge of providing direct-to-patient care for thousands of patients on commercialized medications with complex and rare diseases in their homes. Prior to Coram, he held various management roles with DaVita, Inc., a Fortune 500 Dialysis services provider, and worked in retail pharmacy operations management at Walmart, Sam’s Club, and Target Stores. Additionally, he consulted and worked collaboratively with more than 38 biopharmaceutical companies on pre-launch to commercialization development, launch strategies, and patient access programs for new specialty pharmaceutical therapies. R’Kes received his Bachelor of Science in Pharmacy from Purdue University and his Executive MBA from the Kellogg School of Management at Northwestern University.

Session